Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of an α2-Adrenoceptor Antagonist (Yohimbine) on Dynamic Autoregulation in the Human Middle Cerebral Artery and Ophthalmic Artery

NCT00814047 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT00814047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00814047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of an α2-Adrenoceptor Antagonist (Yohimbine) on Dynamic Autoregulation in the Human Middle Cerebral Artery and Ophthalmic Artery
Lead sponsor
Medical University of Vienna
Phase
Phase 4
Overall status
Completed
Start date
Not reported
Completion date
Not reported
Enrollment
18
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoregulation, blood flow velocity, ocular physiology